{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T23:38:23Z","timestamp":1723160303588},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T00:00:00Z","timestamp":1101772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s10067-004-1020-6","type":"journal-article","created":{"date-parts":[[2004,11,29]],"date-time":"2004-11-29T13:17:40Z","timestamp":1101734260000},"page":"182-186","source":"Crossref","is-referenced-by-count":2,"title":["Marked increase of serum hepatitis C virus (HCV) RNA titer during treatment with high-dose prednisolone in a case of polymyositis"],"prefix":"10.1007","volume":"24","author":[{"given":"Takashi","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Okai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Shiroma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Yokohari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Tadokoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,11,30]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","volume":"345","author":"GM Lauer","year":"2001","unstructured":"Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345:41?52","journal-title":"N Engl J Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/1529-0131(200102)44:2<339::AID-ANR51>3.0.CO;2-Q","volume":"44","author":"S Ito","year":"2001","unstructured":"Ito S, Nakazono K, Murasawa A, Mita Y, Hata K, Saito N et al (2001) Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient. Arthritis Rheum 44:339?342","journal-title":"Arthritis Rheum"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344?347","journal-title":"N Engl J Med"},{"key":"CR4","first-page":"423","volume":"26","author":"H Suzuki","year":"1983","unstructured":"Suzuki H, Ohta Y, Takino T, Fujisawa K, Hirayama C (1983) Effects on glycyrrhizin on biochemical tests in patients with chronic hepatitis-double blind trial. Asian Med J 26:423?438","journal-title":"Asian Med J"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1386-6346(99)00047-9","volume":"16","author":"L Zhang","year":"2000","unstructured":"Zhang L, Cui Z, Wang B (2000) Therapeutic effects of Stronger Neo-Minophagen C (SNMC) in patients with chronic liver disease. Hepatol Res 16:145?154","journal-title":"Hepatol Res"},{"issue":"Suppl 1","key":"CR6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000048283","volume":"62","author":"H Kumada","year":"2002","unstructured":"Kumada H (2002) Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma. Oncology 62 [Suppl 1]:94?100","journal-title":"Oncology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(00)80170-1","volume":"33","author":"M Guilera","year":"2000","unstructured":"Guilera M, Fornes X, Torras X, Enriquez J, Coll S, Sola R et al (2000) Pre-treatment with prednisolone dose not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C. J Hepatol 33:135?141","journal-title":"J Hepatol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.1840190203","volume":"19","author":"S Magrin","year":"1994","unstructured":"Magrin S, Craxi A, Fablano C, Simonetti RG, Fiorentino G, Marino L et al (1994) Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment. Hepatology 19:273?279","journal-title":"Hepatology"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/gast.1996.v110.pm8536853","volume":"110","author":"EJ Gane","year":"1996","unstructured":"Gane EJ, Naoumov NV, Qian KP, Mondelli MU, Maertens G, Portmann BC et al (1996) A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 110:167?177","journal-title":"Gastroenterology"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1128\/JVI.78.3.1513-1524.2004","volume":"78","author":"F Scholle","year":"2004","unstructured":"Scholle F, Li K, Bodola F, Ikeda M, Luxon BA, Lemon SM (2004) Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis. J Virol 78:1513?1524","journal-title":"J Virol"},{"key":"CR11","first-page":"845","volume-title":"Robbins pathologic basis of disease","author":"JM Crawford","year":"1999","unstructured":"Crawford JM (1999) The liver and the biliary tract. In: Cotran RS, Kumar V, Collins T (eds) Robbins pathologic basis of disease, 6th edn. W.B. Saunders, Philadelphia, pp 845?901","edition":"6"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2249.1998.00469.x","volume":"111","author":"B Kallinowski","year":"1998","unstructured":"Kallinowski B, Haseroth K, Marinos G, Hanck C, Seremmel W, Theilmann L et al (1998) Induction of tumor necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 111:269?277","journal-title":"Clin Exp Immunol"},{"key":"CR13","first-page":"16339","volume":"276","author":"H Yoshida","year":"2001","unstructured":"Yoshida H, Kato N, Shiratori Y, Otsuka M, Maeda S, Kato J et al (2001) Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor. J Biol Chem 276:16339?16405","journal-title":"J Biol Chem"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1128\/JVI.72.5.3691-3697.1998","volume":"72","author":"N Zhu","year":"1998","unstructured":"Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C et al (1998) Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 72:3691?3697","journal-title":"J Virol"},{"key":"CR15","first-page":"3386","volume":"84","author":"A Aljada","year":"1999","unstructured":"Aljada A, Ghanim H, Assian E, Mohanty P, Hamouda W, Garg R et al (1999) Increased IkappaB expression and diminished nuclear NF-kappaB in human mononuclear cells following hydrocortisone injection. J Clin Endocrinol Metab 84:3386?3389","journal-title":"J Clin Endocrinol Metab"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1210\/jcem.86.12.8212","volume":"86","author":"A Aljada","year":"2001","unstructured":"Aljada A, Ghanim H, Mohanty P, Hofmeyer D, Tripathy D, Dandona P et al (2001) Hydrocortisone suppresses intranuclear activator-protein-1 (AP-1) binding activity in mononuclear cells and plasma matrix metalloproteinase 2 and 9 (MMP-2 and MMP-9). J Clin Endocrinol Metab 86:5988?5991","journal-title":"J Clin Endocrinol Metab"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/ard.62.11.1078","volume":"62","author":"JR Peterson","year":"2003","unstructured":"Peterson JR, Hsu FC, Simkin PA, Wener MH (2003) Effect of tumor necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis 62:1078?1082","journal-title":"Ann Rheum Dis"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/gast.2002.36610","volume":"123","author":"L Alric","year":"2002","unstructured":"Alric L, Di-Martino V, Selves J, Cacoub P, Charlotte F, Reynaud D et al (2002) Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection. Gastroenterology 123:1494?1499","journal-title":"Gastroenterology"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00007890-200208270-00001","volume":"74","author":"E Gane","year":"2002","unstructured":"Gane E, Pilmore H (2002) Management of chronic viral hepatitis before and after renal transplantation. Transplantation 74:427?437","journal-title":"Transplantation"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1248\/bpb.22.951","volume":"22","author":"M Yoshikawa","year":"1999","unstructured":"Yoshikawa M, Toyohara M, Ueda S, Shiroi A, Takeuchi H, Nishiyama T et al (1999) Glycyrrhizin inhibits TNF-induced, but not Fas-mediated, apoptosis in the human hepatoblastoma line HepG2. Biol Pharm Bull 22:951?955","journal-title":"Biol Pharm Bull"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-1020-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-004-1020-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-1020-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T11:24:34Z","timestamp":1585999474000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-004-1020-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,30]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["1020"],"URL":"https:\/\/doi.org\/10.1007\/s10067-004-1020-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,30]]}}}